1. Home
  2. APGE vs KN Comparison

APGE vs KN Comparison

Compare APGE & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • KN
  • Stock Information
  • Founded
  • APGE 2022
  • KN 1946
  • Country
  • APGE United States
  • KN United States
  • Employees
  • APGE N/A
  • KN N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • KN Consumer Electronics/Appliances
  • Sector
  • APGE Health Care
  • KN Consumer Staples
  • Exchange
  • APGE Nasdaq
  • KN Nasdaq
  • Market Cap
  • APGE 2.4B
  • KN 2.0B
  • IPO Year
  • APGE 2023
  • KN N/A
  • Fundamental
  • Price
  • APGE $54.65
  • KN $23.73
  • Analyst Decision
  • APGE Strong Buy
  • KN Buy
  • Analyst Count
  • APGE 8
  • KN 3
  • Target Price
  • APGE $94.63
  • KN $22.33
  • AVG Volume (30 Days)
  • APGE 972.3K
  • KN 701.6K
  • Earning Date
  • APGE 11-12-2025
  • KN 10-23-2025
  • Dividend Yield
  • APGE N/A
  • KN N/A
  • EPS Growth
  • APGE N/A
  • KN N/A
  • EPS
  • APGE N/A
  • KN 0.48
  • Revenue
  • APGE N/A
  • KN $573,500,000.00
  • Revenue This Year
  • APGE N/A
  • KN $8.20
  • Revenue Next Year
  • APGE N/A
  • KN $5.13
  • P/E Ratio
  • APGE N/A
  • KN $57.50
  • Revenue Growth
  • APGE N/A
  • KN 4.24
  • 52 Week Low
  • APGE $26.20
  • KN $12.19
  • 52 Week High
  • APGE $63.50
  • KN $24.54
  • Technical
  • Relative Strength Index (RSI)
  • APGE 61.62
  • KN 56.13
  • Support Level
  • APGE $54.80
  • KN $23.36
  • Resistance Level
  • APGE $57.00
  • KN $24.29
  • Average True Range (ATR)
  • APGE 2.81
  • KN 0.66
  • MACD
  • APGE -0.36
  • KN -0.05
  • Stochastic Oscillator
  • APGE 43.83
  • KN 56.05

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

Share on Social Networks: